域特异性抗体揭示血清与足细胞中APOL1膜拓扑结构差异
该研究用170种APOL1域特异性单克隆抗体,通过流式细胞术、免疫沉淀和锥虫溶解试验,比较血清HDL颗粒与肾足细胞表面APOL1的拓扑结构。结果显示足细胞表面暴露孔形成域和SRA-ID的C端,而血清APOL1暴露膜定位域;低pH未改变总体拓扑。结论支持表面离子通道模型解释APOL1风险变异介导的足细胞损伤。
要点
- 足细胞表面APOL1的孔形成域和SRA-ID C端暴露,膜定位域不暴露。
- 血清APOL1中膜定位域暴露,孔形成域可及性较低。
- 低pH未检测到血清或足细胞APOL1总体拓扑改变。
核心结论
- 天然APOL1在血清HDL颗粒与足细胞表面的拓扑构象不同。
- 研究结果支持表面离子通道模型解释APOL1风险变异介导的足细胞损伤。
- 域可及性信息可为设计APOL1靶向治疗提供依据。
研究设计与样本
- 用流式细胞术、免疫沉淀和锥虫溶解试验追踪170种APOL1域特异性单克隆抗体。
- APOL1敲除足细胞用于确认抗体特异性。
主要发现
- 足细胞表面APOL1暴露大部分孔形成域和SRA-ID的C端,但膜定位域不暴露。
- 血清APOL1中膜定位域暴露,孔形成域可及性较低。
- 低pH未检测到血清或足细胞APOL1总体拓扑改变。
临床怎么用
- 理解APOL1在足细胞表面的拓扑有助于解释风险变异致病机制。
- 域可及性信息可用于设计靶向APOL1的治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Circulating APOL1 lyses trypanosomes, protecting against human sleeping sickness. Two common African gene variants of APOL1, G1 and G2, protect against infection by species of trypanosomes that resist wild-type APOL1. At the same time, the protection predisposes humans to CKD, an elegant example of balanced polymorphism. However, the exact mechanism of APOL1-mediated podocyte damage is not clear, including APOL1's subcellular localization, topology, and whether the damage is related to trypanolysis. METHODS: APOL1 topology in serum (HDL particles) and in kidney podocytes was mapped with flow cytometry, immunoprecipitation, and trypanolysis assays that tracked 170 APOL1 domain-specific monoclonal antibodies. APOL1 knockout podocytes confirmed antibody specificity. RESULTS: APOL1 localizes to the surface of podocytes, with most of the pore-forming domain (PFD) and C terminus of the Serum Resistance Associated-interacting domain (SRA-ID), but not the membrane-addressing domain (MAD), being exposed. In contrast, differential trypanolytic blocking activity reveals that the MAD is exposed in serum APOL1, with less of the PFD accessible. Low pH did not detectably alter the gross topology of APOL1, as determined by antibody accessibility, in serum or on podocytes. CONCLUSIONS: Our antibodies highlighted different conformations of native APOL1 topology in serum (HDL particles) and at the podocyte surface. Our findings support the surface ion channel model for APOL1 risk variant-mediated podocyte injury, as well as providing domain accessibility information for designing APOL1-targeted therapeutics.
引用
- Gupta N, Wang X, Wen X, et al. Domain-Specific Antibodies Reveal Differences in the Membrane Topologies of Apolipoprotein L1 in Serum and Podocytes. J Am Soc Nephrol. 2020. PMID: 32764138. doi:10.1681/ASN.2019080830
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。